Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479112 · ClinicalTrials.gov registry record · NA
Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
A NA study of Traumatic Hemorrhage, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 562
- Enrollment target
- 1
- Study location
NCT03479112: Completed NA study of Traumatic Hemorrhage, sponsored by Brigham and Women's Hospital.
NCT03479112 is a NA study of Traumatic Hemorrhage that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 562 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479112, a NA study of Traumatic Hemorrhage, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 562 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled study evaluating the ability of laypersons to correctly apply a tourniquet using different instructional methods. There are four arms being evaluated: flashcards, audio-kit with visual aids, formal in person Bleeding Control Basic (B-Con) course, and a control arm. All participants will then undergo B-Con training at the end of each session and then participants will be evaluated within a 3-6 month time period to evaluate their retention of knowledge and skills taught by the B-Con course.
Primary Outcome
Correct Tourniquet Application ( Yes/No) is comprised of 3 measures (participants must succeed at All 3 Elements: Length of Time, Tension, Location must be correct for appropriate tourniquet application) 1. Timing (Minutes and Seconds) 2. Tension (Tightness) of Tourniquet (Yes or No, is determined by attempting to forcefully slide a Kelly clamp under between the tourniquet and the extremity of the mannequin) 3. Location of Tourniquet ( Measurement in Inches from wound site )
Conditions Studied
Interventions
- BEHAVIORAL Flashcards
- BEHAVIORAL Audio-kit
- BEHAVIORAL B-Con training
- BEHAVIORAL B-Con training retention
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2018-01-30 |
| Phase | NA |
What the finished NCT03479112 record still lists
NCT03479112 is an interventional study that assigns participants to a tested intervention. The registered 562 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Traumatic Hemorrhage appearing as the primary indexed condition, and to 4 interventions - of which Flashcards is the first listed.
NCT03479112 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03479112 about?
NCT03479112 is a clinical study titled "Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial". This is a randomized controlled study evaluating the ability of laypersons to correctly apply a tourniquet using different instructional methods. There are four arms being evaluated: flashcards, audio-kit with visual aids, formal in person Bleeding Control Basic (B-Con) course, and a control arm. Al...
What is the current status of trial NCT03479112?
This trial is currently completed. It is a NA study. The enrollment target is 562 participants. The study started on 2017-05-22. Estimated completion is 2018-01-30.
What conditions does trial NCT03479112 study?
This clinical trial studies the following conditions: Traumatic Hemorrhage.
What interventions are being tested in trial NCT03479112?
The interventions under investigation include: Flashcards (BEHAVIORAL), Audio-kit (BEHAVIORAL), B-Con training (BEHAVIORAL), B-Con training retention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03479112?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03479112 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03479112's enrollment target sits among peer trials
562 181st of 2000 higher than 1,820 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07007065 · 561 participants · Phase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI